Sokolenko, A.P.; Moiseyenko, F.V.; Iyevleva, A.G.; Ivantsov, A.O.; Dolmatov, G.D.; Shelekhova, K.V.; Gulo, E.V.; Topal, A.X.; Artemieva, E.V.; Abduloeva, N.H.;
et al. Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. Int. J. Mol. Sci. 2023, 24, 1870.
https://doi.org/10.3390/ijms24031870
AMA Style
Sokolenko AP, Moiseyenko FV, Iyevleva AG, Ivantsov AO, Dolmatov GD, Shelekhova KV, Gulo EV, Topal AX, Artemieva EV, Abduloeva NH,
et al. Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. International Journal of Molecular Sciences. 2023; 24(3):1870.
https://doi.org/10.3390/ijms24031870
Chicago/Turabian Style
Sokolenko, Anna P., Fedor V. Moiseyenko, Aglaya G. Iyevleva, Alexandr O. Ivantsov, Georgiy D. Dolmatov, Ksenia V. Shelekhova, Elizaveta V. Gulo, Anastasya X. Topal, Elizaveta V. Artemieva, Nuriniso H. Abduloeva,
and et al. 2023. "Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients" International Journal of Molecular Sciences 24, no. 3: 1870.
https://doi.org/10.3390/ijms24031870
APA Style
Sokolenko, A. P., Moiseyenko, F. V., Iyevleva, A. G., Ivantsov, A. O., Dolmatov, G. D., Shelekhova, K. V., Gulo, E. V., Topal, A. X., Artemieva, E. V., Abduloeva, N. H., Rysev, N. A., Barsova, D. A., Levchenko, N. V., Volkov, N. M., Egorenkov, V. V., Moiseyenko, V. M., & Imyanitov, E. N.
(2023). Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. International Journal of Molecular Sciences, 24(3), 1870.
https://doi.org/10.3390/ijms24031870
